Kindly MD Net Income

NAKA Stock   0.28  0.01  3.70%   
As of the 13th of February 2026, Kindly MD secures the Standard Deviation of 6.71, risk adjusted performance of (0.15), and Mean Deviation of 4.95. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Kindly MD, as well as the relationship between them.

Kindly MD Total Revenue

3.51 Million

Kindly MD's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Kindly MD's valuation are provided below:
Gross Profit
-1.5 M
Profit Margin
(1.77)
Market Capitalization
83 M
Enterprise Value Revenue
33.6126
Revenue
2.5 M
We have found one hundred twenty available fundamental ratios for Kindly MD, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Kindly MD last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of February 13, 2026, Enterprise Value is expected to decline to about 401.4 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-3.3 M-3.1 M
Net Loss-3.3 M-3.1 M
Net Loss(0.77)(0.73)
The current year's Net Loss is expected to grow to about (3.1 M). The current year's Net Loss is expected to grow to about (3.1 M).
  
Build AI portfolio with Kindly Stock
Analyzing Kindly MD's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Kindly MD's current valuation and future prospects.

Latest Kindly MD's Net Income Growth Pattern

Below is the plot of the Net Income of Kindly MD over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Kindly MD financial statement analysis. It represents the amount of money remaining after all of Kindly MD operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Kindly MD's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kindly MD's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (3.62 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Kindly Net Income Regression Statistics

Arithmetic Mean(725,449)
Coefficient Of Variation(199.90)
Mean Deviation1,234,991
Median149,336
Standard Deviation1,450,152
Sample Variance2.1T
Range3.8M
R-Value(0.78)
Mean Square Error861B
R-Squared0.62
Significance0.0002
Slope(225,420)
Total Sum of Squares33.6T

Kindly Net Income History

2026-3.1 M
2025-3.3 M
2024-3.6 M
2023-1.6 M
2022-2.5 M

Other Fundumenentals of Kindly MD

Kindly Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Kindly MD is extremely important. It helps to project a fair market value of Kindly Stock properly, considering its historical fundamentals such as Net Income. Since Kindly MD's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kindly MD's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kindly MD's interrelated accounts and indicators.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kindly MD. Anticipated expansion of Kindly directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Kindly MD assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.73)
Revenue Per Share
0.43
Quarterly Revenue Growth
(0.30)
Return On Assets
(1.54)
Return On Equity
(7.63)
Investors evaluate Kindly MD using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Kindly MD's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Kindly MD's market price to deviate significantly from intrinsic value.
It's important to distinguish between Kindly MD's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Kindly MD should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Kindly MD's market price signifies the transaction level at which participants voluntarily complete trades.

Kindly MD 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kindly MD's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kindly MD.
0.00
11/15/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/13/2026
0.00
If you would invest  0.00  in Kindly MD on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Kindly MD or generate 0.0% return on investment in Kindly MD over 90 days. Kindly MD is related to or competes with Agilon Health, Definitive Healthcare, Sophia Genetics, Lyell Immunopharma, Larimar Therapeutics, Simulations Plus, and Cellectis. Kindly MD is entity of United States. It is traded as Stock on NASDAQ exchange. More

Kindly MD Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kindly MD's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kindly MD upside and downside potential and time the market with a certain degree of confidence.

Kindly MD Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Kindly MD's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kindly MD's standard deviation. In reality, there are many statistical measures that can use Kindly MD historical prices to predict the future Kindly MD's volatility.
Hype
Prediction
LowEstimatedHigh
0.010.227.09
Details
Intrinsic
Valuation
LowRealHigh
0.010.277.14
Details

Kindly MD February 13, 2026 Technical Indicators

Kindly MD Backtested Returns

Kindly MD has Sharpe Ratio of -0.13, which conveys that the firm had a -0.13 % return per unit of risk over the last 3 months. Kindly MD exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kindly MD's Risk Adjusted Performance of (0.15), mean deviation of 4.95, and Standard Deviation of 6.71 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.85, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kindly MD will likely underperform. At this point, Kindly MD has a negative expected return of -0.89%. Please make sure to verify Kindly MD's maximum drawdown and the relationship between the kurtosis and price action indicator , to decide if Kindly MD performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.61  

Good predictability

Kindly MD has good predictability. Overlapping area represents the amount of predictability between Kindly MD time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kindly MD price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current Kindly MD price fluctuation can be explain by its past prices.
Correlation Coefficient0.61
Spearman Rank Test0.55
Residual Average0.0
Price Variance0.01
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Kindly Operating Income

Operating Income

(3.16 Million)

At present, Kindly MD's Operating Income is projected to decrease significantly based on the last few years of reporting.
Based on the recorded statements, Kindly MD reported net income of (3.62 Million). This is 101.06% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.63% higher than that of the company.

Kindly Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kindly MD's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kindly MD could also be used in its relative valuation, which is a method of valuing Kindly MD by comparing valuation metrics of similar companies.
Kindly MD is currently under evaluation in net income category among its peers.

Kindly Fundamentals

About Kindly MD Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Kindly MD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kindly MD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kindly MD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Kindly MD is a strong investment it is important to analyze Kindly MD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kindly MD's future performance. For an informed investment choice regarding Kindly Stock, refer to the following important reports:
Check out
For information on how to trade Kindly Stock refer to our How to Trade Kindly Stock guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kindly MD. Anticipated expansion of Kindly directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Kindly MD assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.73)
Revenue Per Share
0.43
Quarterly Revenue Growth
(0.30)
Return On Assets
(1.54)
Return On Equity
(7.63)
Investors evaluate Kindly MD using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Kindly MD's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Kindly MD's market price to deviate significantly from intrinsic value.
It's important to distinguish between Kindly MD's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Kindly MD should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Kindly MD's market price signifies the transaction level at which participants voluntarily complete trades.